Pharmaceutical Quality Controls Market is valued at USD 6.4 Billion in 2019 and expected to reach USD 11.41 Billion by 2026 with the CAGR of 8.6% over the forecast period.
Pharmaceutical Quality Controls Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2026- Rising spending on pharmaceutical industry and launch of new medicinal products are some of the major factors driving the growth of the Global Pharmaceutical Quality Controls Market.
Scope of Global Pharmaceutical Quality Controls Market Report-
The quality control refers to the total of all procedures to make sure the identity and purity of a selected pharmaceutical. Quality control is used to perform the pharmaceutical business. The pharmaceutical quality control liableness and accuracy area unit is an essential function of the pharmaceutical industry. Drug makers should completely check materials, processes, equipment, techniques, environments and personnel so as to make sure their final products area unit consistent, safe, effective and predictable. Quality control involves testing of units to approval for the final product. For example, inspection is the common method used for quality control purposes not only in production but also in services. Another example is statistical quality control which is an advanced method or technique used to control the quality of a product.
Global Pharmaceutical Quality Controls Market report is segmented on the basis of product, analysis type, product tested and by regional & country level. Based upon product, global pharmaceutical quality controls market is segmented into consumables, instruments and services. Based upon analysis type, global pharmaceutical quality controls market is segmented into sterility testing, bioburden testing, endotoxin testing, stability testing, extractable & leachable testing, raw material testing, others. Based upon product tested, global pharmaceutical quality controls market is segmented into vaccines, plasma product, drugs
The regions covered in this pharmaceutical quality controls market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of pharmaceutical quality controls is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players of Pharmaceutical Quality Controls-
Pharmaceutical quality controls market report covers prominent Sartorious AG, WuXi AppTec, bioMérieux SA, Inc., Charles River Laboratories International, Toxikon Corporation Thermo Fisher Scientific, Inc., Merck KGaA, SGS S.A., Eurofins Scientific and others.
Global Pharmaceutical Quality Controls Market Dynamics –
Rising spending on pharmaceutical industry and launch of new medicinal products, are some of the major factors driving the growth of the global pharmaceutical quality controls market. The global pharmaceutical market will reach nearly USD 1,430 billion by 2020, According to International Federation of Pharmaceutical Manufacturers & Associations. In addition, there is a high demand for pharmaceutical quality controls due to occurrence of COVID-19 globally. Quality control is an essential operation of the pharmaceutical industry to ensure the identity and purity of a particular pharmaceutical. For instance; the U.S. biopharmaceutical industry has been the world leader in the development of new medicines, The members of the Pharmaceutical Research and Manufacturing Association had invested an estimated $102 billion in research and development in 2018 continue to be at the forefront.
The biopharmaceutical industry invested an estimated USD102 billion in researches and development (R&D) in 2018 for establishing the biopharmaceutical sector. This increasing investments and product development are also fostering the market growth. According to National Conference of State Legislatures, as of 2015, about 36 % of total pharmaceutical spending in the commercial market was devoted to specialty medications. In 2017, FDA announced the Drug Competition Action Plan (DCAP) to further boost robust and timely market competition for generic drugs and help bring greater efficiency and transparency to the generic drug review process.
Additionally, though this plan FDA is helping remove barriers to generic drug development and market entry in an effort to incentive competition so that consumers can get access to the medicines. For instance; new drug therapy to help a wide range of patients suffering from many different medical conditions, rare disorders to common diseases approved by FDA’s Center for Drug Evaluation and Research’s (CDER’s) in 2017.
However, technical issues associated with quality control systems is the major restrains of the global pharmaceutical quality controls market. In spite of that, technological advancements and improvement in quality control system, changes in drug policies and regulations by government may generate new opportunities for pharmaceutical quality controls market growth.
Global Pharmaceutical Quality Controls Market Regional Analysis –
North America is expected to dominate the global pharmaceutical quality controls market with highest shares followed by Europe, due to heavy investment in R&D expenditures, technological expansions and integration of innovative technologies and presence of major players in this region. In 2017, a wide variety of drug therapies to improve the health of the American public approved by The Center for Drug Evaluation and Research (CDER). According to International Federation of Pharmaceutical Manufacturers & Associations, The United States share of the global market will increase from 40.3% to 41% in2015 to 2020. As per study report, the research-based pharmaceutical industry currently spends over USD 149.8 billion on R&D per year. Thus, a heavy investment in R&D for the pharmaceutical industry is expected to drive the pharmaceutical quality controls market over the forecast period. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2017, the research-based pharmaceutical industry invested an estimated € 35,200 million in R&D in Europe.
Asia Pacific market is expected to witness a significant growth majorly due a rise in investment for the pharmaceutical industry and rising adoption of advanced technologies in this region. According to research report, there is rapid growth in the market and research environment in emerging economies such as Brazil, China and India, during the period 2013-2017 the Brazilian, Chinese and Indian markets grew by 11.5%, 9.4% and 11.0% respectively.
Key Benefits for Pharmaceutical Quality Controls Market Report–
Global pharmaceutical quality controls Market report covers in depth historical and forecast analysis.
Global pharmaceutical quality controls Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global pharmaceutical quality controls Market report helps to identify opportunities in market place.
Global pharmaceutical quality controls Market report covers extensive analysis of emerging trends and competitive landscape.
Global Pharmaceutical Quality Controls Market Segmentation:–
By Product:
Consumables
Instruments
Services
By Analysis Type:
Sterility Testing
Bioburden Testing
Endotoxin Testing
Stability Testing
Extractable & Leachable Testing
Raw Material Testing
Others Parenteral
By Product Tested:
Vaccines
Plasma Product
Drugs
By Regional & Country Analysis:
North America
U.S.
Mexico
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
South America
Brazil
Argentina
Columbia
The Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
About Us:
Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at [email protected]
Rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support are the key factor driving market growth.The Molecular Quality Controls Market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period.Ask for PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82625523Market Segmentation:-Based on product type, the molecular controls market is divided into two major segments—instrument-specific controls and independent controls.
The independent controls segment accounted for a larger share of the molecular controls market in 2018.
The large share of this segment is attributed to the increasing use of third-party independent quality controls due to their benefits such as longer shelf-life and flexible use across different reagent lots, which help reduce the cost of operations.By analyte type, the molecular controls market is segmented into single-analyte controls and multi-analyte controls.
Single-analyte controls dominated the molecular controls market in 2018 primarily due to the significant use of singleplex assays in hospitals and the advantages associated with the use of single-analyte controls, such as simple analysis & interpretation and low risk of cross-reactivity.Recent Developments:-In 2018, Seracare partnered with AccuRef Diagnostics, a division of Applied StemCell, Inc (US), to market and sell Accuref’s broad portfolio of CRISPR-engineered cell line reference materials.In 2018, Thermo Fisher Scientific partnered with West China Hospital of Sichuan University (China) to establish training centers for standardized pathology quality control, standardized pathologic diagnosticians, and advanced laboratories.In 2017, Bio-Rad launched Amplichek STI—a Multi-analyte Quality ControlIn 2018, Microbiologics launched 8 quality control products such as, Human Papillomavirus (HPV) Control Panel, Vaginal Control Panel, Vaginal Verification Panel, Blood Culture (BCID) Control Panel, Enteric Viral Control Panel and others.Regional Analysis:-North America held the largest share of the market in 2018, Asia Pacific is estimated to grow at the highest CAGR during the forecast period.Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=82625523 Top Key Players:-The prominent players in the molecular quality controls market are SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US).
According to research report the global IVD quality control market is expected to reach USD 1.04 billion by 2022, at a CAGR of 3.5% from 2017 to 2022.
The global IVD quality controls market is oligopolistic in nature with very few players accounting for a major share of the market.
Bio-Rad Laboratories, Inc. (U.S.), Randox Laboratories (U.K.), and Thermo Fisher Scientific, Inc. (U.S.) are the major players in this market.
A majority of the leading players in this market are based in developed countries across North America and Europe.Read more: https://www.marketsandmarkets.com/PressReleases/in-vitro-diagnostics-quality-controls.aspIn 2016, Bio-Rad Laboratories held the leading position in the IVD quality controls market.
This can be attributed to its highly diversified quality controls portfolio, which includes controls for immunoassay, therapeutic drug monitoring, serum chemistry, and urine chemistry; urinalysis controls; cardiac assessment quality controls; immunology/protein controls; hematology, blood gas, diabetes/hemoglobin, and infectious disease controls; molecular quality controls; and specialty quality controls.
The company also offers third party quality controls, data management solutions, educational services, and customer support to clinical laboratories.In 2016, Randox Laboratories held the second largest share of the IVD quality controls market.
